ストックスクリーナーアプリを入手
44.83
0.85%
0.38
プレマーケット:
45.56
0.73
+1.63%
前日終値:
$44.45
開ける：
$44.63
24時間の取引高:
404.83K
Relative Volume:
0.68
時価総額：
$3.10B
収益：
$35.93M
当期純損益:
$-244.56M
株価収益率:
-11.35
EPS:
-3.95
ネットキャッシュフロー:
$-157.31M
1週間 パフォーマンス:
-7.20%
1か月 パフォーマンス:
-3.01%
6か月 パフォーマンス:
-6.10%
1年 パフォーマンス:
+0.18%
1日の値動き範囲:
$44.41
$45.69
1週間の範囲:
$44.20
$49.80
52週間の値動き範囲:
$37.77
$61.61
Merus N V Stock (MRUS) Company Profile
MRUS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MRUS
Merus N V
|
44.83 | 3.10B | 35.93M | -244.56M | -157.31M | -3.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.55 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
635.83 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
593.47 | 36.20B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.02 | 35.08B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
262.60 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Merus N V Stock (MRUS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-13 | 開始されました | Piper Sandler | Overweight |
| 2025-02-07 | 開始されました | Wells Fargo | Overweight |
| 2024-11-21 | 開始されました | Goldman | Buy |
| 2024-10-24 | 開始されました | UBS | Buy |
| 2024-03-28 | 開始されました | Truist | Buy |
| 2024-03-04 | 繰り返されました | Needham | Buy |
| 2023-11-02 | 開始されました | Canaccord Genuity | Buy |
| 2023-08-21 | 開始されました | TD Cowen | Outperform |
| 2022-08-02 | 開始されました | Stifel | Buy |
| 2022-02-11 | 開始されました | BMO Capital Markets | Outperform |
| 2022-02-10 | 開始されました | Needham | Buy |
| 2021-11-17 | 再開されました | Guggenheim | Buy |
| 2021-06-07 | アップグレード | Citigroup | Neutral → Buy |
| 2021-04-08 | 開始されました | William Blair | Outperform |
| 2021-03-16 | 開始されました | SVB Leerink | Outperform |
| 2020-06-26 | 開始されました | H.C. Wainwright | Buy |
| 2020-05-27 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-11-20 | 再開されました | Guggenheim | Buy |
| 2019-06-28 | 開始されました | ROTH Capital | Buy |
| 2019-04-12 | 再開されました | Guggenheim | Buy |
| 2019-04-03 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-03-27 | 開始されました | Berenberg | Buy |
| 2018-01-02 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2017-09-15 | 開始されました | RBC Capital Mkts | Outperform |
| 2017-03-21 | ダウングレード | Citigroup | Buy → Neutral |
| 2016-12-22 | アップグレード | Citigroup | Neutral → Buy |
| 2016-11-07 | ダウングレード | Citigroup | Buy → Neutral |
| 2016-06-13 | 開始されました | Citigroup | Buy |
| 2016-06-13 | 開始されました | Guggenheim | Buy |
| 2016-06-13 | 開始されました | Wedbush | Outperform |
すべてを表示
Merus N V (MRUS) 最新ニュース
Swiss National Bank Purchases 8,300 Shares of Merus (NASDAQ:MRUS) - Defense World
Merus VP controller Shuman sells $193,990 in common shares By Investing.com - Investing.com Australia
Merus VP controller Shuman sells $193,990 in common shares - Investing.com
Bank of New York Mellon Corp Sells 1,248 Shares of Merus (NASDAQ:MRUS) - Defense World
US Bancorp DE Lowers Holdings in Merus (NASDAQ:MRUS) - Defense World
Merus (NASDAQ:MRUS) Given “Buy” Rating at Guggenheim - Defense World
Merus (NASDAQ:MRUS) Given Average Recommendation of “Buy” by Brokerages - Defense World
Merus (NASDAQ:MRUS) Given New $70.00 Price Target at Bank of America - Defense World
Why Merus Shares Are Facing Pressure Today - TipRanks
Merus (NASDAQ:MRUS) Short Interest Down 13.5% in February - Defense World
Stifel maintains Buy on Merus stock with $93 target By Investing.com - Investing.com Australia
Stifel maintains Buy on Merus stock with $93 target - Investing.com
Merus N.V. Reports 2024 Earnings and Clinical Progress - TipRanks
Need To Know: The Consensus Just Cut Its Merus N.V. (NASDAQ:MRUS) Estimates For 2025 - Simply Wall St
Merus (NASDAQ:MRUS) Receives “Buy” Rating from HC Wainwright - Defense World
Merus stock holds Buy rating and $85 target from H.C. Wainwright - Investing.com India
Merus stock holds Buy rating and $85 target from H.C. Wainwright By Investing.com - Investing.com South Africa
Merus’ (MRUS) Outperform Rating Reiterated at William Blair - Defense World
Needham & Company LLC Cuts Merus (NASDAQ:MRUS) Price Target to $83.00 - Defense World
Earnings Update: Merus N.V. (NASDAQ:MRUS) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts - Simply Wall St
Merus N.V. (MRUS) Reports Q4 Loss, Lags Revenue Estimates - MSN
Analyst Forecasts Just Became More Bearish On Merus N.V. (NASDAQ:MRUS) - Yahoo Canada Finance
Merus (NASDAQ:MRUS) Posts Quarterly Earnings Results, Beats Estimates By $0.48 EPS - MarketBeat
BMO Capital lifts Merus stock target to $96, maintains Outperform By Investing.com - Investing.com South Africa
BMO Capital lifts Merus stock target to $96, maintains Outperform - Investing.com
Merus Shares Soar Amid Breakthrough Therapy Hopes - TipRanks
Merus NV reports results for the quarter ended December 31Earnings Summary - TradingView
Merus N.V. Updates on Petosemtamab Trials and Financial Outlook for 2025 and Beyond - Nasdaq
Merus Announces Financial Results for the Fourth Quarter and Full Year 2024 and Provides Business Update - GlobeNewswire
Merus Secures FDA Approval for Cancer Drug With $724M War Chest to Fund Operations Through 2028 - StockTitan
Merus N.V. SEC 10-K Report - TradingView
Merus N.V. to Host Earnings Call - ACCESS Newswire
Investor Network: Merus N.V. to Host Earnings Call - ACCESS Newswire
State of New Jersey Common Pension Fund D Buys 10,842 Shares of Merus (NASDAQ:MRUS) - MarketBeat
Merus to Present at Upcoming Investor Conferences - GlobeNewswire
Clinical-Stage Oncology Innovator Merus Schedules Two Major Investor Presentations - StockTitan
Merus (MRUS) to Release Quarterly Earnings on Wednesday - MarketBeat
Innate Pharma and Merus gets FDA Breakthrough Therapy Designation for their respective treatments - MSN
TimesSquare Capital Management LLC Purchases 58,760 Shares of Merus (NASDAQ:MRUS) - MarketBeat
Merus Stock Soars on Cancer Treatment Breakthrough - TipRanks
La FDA américaine a accordé le statut de thérapie innovante au pétosemtamab dans le carcinome épidermoïde de la tête et du cou positif PD-L1 positif en 1re ligne - GlobeNewswire Inc.
Merus Shares Are Up Today: What's Going On?Merus (NASDAQ:MRUS) - Benzinga
Merus N V (MRUS) 財務データ
収益
当期純利益
現金流量
EPS
Merus N V (MRUS) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Shuman Harry | VP Controller, PAO |
Jan 01 '25 |
Option Exercise |
0.00 |
5,000 |
0 |
12,002 |
| Lundberg Sven Ante | President, CEO & PEO |
Feb 13 '25 |
Option Exercise |
24.43 |
16,372 |
399,968 |
40,601 |
| Shuman Harry | VP Controller, PAO |
Aug 21 '24 |
Sale |
54.00 |
2,500 |
135,000 |
7,002 |
| Shuman Harry | VP Controller, PAO |
Aug 20 '24 |
Sale |
54.00 |
2,500 |
135,000 |
7,002 |
| Silverman Peter B. | COO & GC |
Jun 27 '24 |
Option Exercise |
17.94 |
10,000 |
179,400 |
10,000 |
| Silverman Peter B. | COO & GC |
Jun 27 '24 |
Sale |
60.00 |
10,000 |
600,000 |
0 |
| Silverman Peter B. | COO & GC |
Jun 17 '24 |
Option Exercise |
24.36 |
62,000 |
1,510,280 |
62,000 |
| Silverman Peter B. | COO & GC |
Jun 17 '24 |
Sale |
56.52 |
62,000 |
3,504,178 |
0 |
| Shuman Harry | VP Controller, PAO |
Jun 12 '24 |
Sale |
57.84 |
7,300 |
422,232 |
7,002 |
| Shuman Harry | VP Controller, PAO |
Jun 10 '24 |
Sale |
53.22 |
1,000 |
53,224 |
7,002 |
1.46%
0.90%
大文字化:
|
ボリューム (24 時間):